Abate Kristin sold KPTI
May 14, 2026 · Form 4 insider transaction
Abate Kristin sold 53 shares of Karyopharm Therapeutics Inc. at $9.50 per share, a transaction worth $503.50. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
53
Price
$9.50
Total value
$503.50
InsiderAbate Kristin
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMay 14, 2026
Filing dateMay 15, 2026
Shares owned after23,801
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 27, 2021, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of PSUs. The sale does not represent a discretionary trade by the reporting person.